Early HBV Treatment
How to Implement Earlier Hepatitis B Treatment

Released: March 26, 2024

Jacki Chen
Jacki Chen, PhD
Tatyana Kushner
Tatyana Kushner, MD, MSCE
Paul Y. Kwo
Paul Y. Kwo, MD
Mark S. Sulkowski
Mark S. Sulkowski, MD, FIDSA, FAASLD

Activity

Progress
1
Course Completed

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include:

  • Patient subgroups to consider for treatment outside guideline criteria
  • Adverse event and cost-effectiveness considerations
  • Integration of patient perspectives in wider treatment